B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis

Can Ulutekin, Edoardo Galli, Bettina Schreiner, Mohsen Khademi, Ilaria Callegari, Fredrik Piehl, Nicholas Sanderson, Daniel S. Kirschenbaum, Sarah Mundt, Massimo Filippi,

Cell Reports Medicine · 2023 · 17 citations · 72 references

DOIFull text

Open access

Concepts

Abstract

Multiple sclerosis is a chronic inflammatory disease of the central nervous system. Whereas T cells are likely the main drivers of disease development, the striking efficacy of B cell-depleting therapies (BCDTs) underscore B cells' involvement in disease progression. How B cells contribute to multiple sclerosis (MS) pathogenesis-and consequently the precise mechanism of action of BCDTs-remains elusive. Here, we analyze the impact of BCDTs on the immune landscape in patients with MS using high-dimensional single-cell immunophenotyping. Algorithm-guided analysis reveals a decrease in circulating T follicular helper-like (Tfh-like) cells alongside increases in CD27 expression in memory T helper cells and Tfh-like cells. Elevated CD27 indicates disrupted CD27/CD70 signaling, as sustained CD27 activation in T cells leads to its cleavage. Immunohistological analysis shows CD70-expressing B cells at MS lesion sites. These results suggest that the efficacy of BCDTs may partly hinge upon the disruption of Th cell and B cell interactions.

References

72